Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell

doi:10.3748/wjg.v9.i9.1995

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3071)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

322

HTML

2513

Figures (1-3)

112

Tables (1-1)

124

Sum=3071

Sep 15, 2003 (publication date) through Apr 16, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Colorectal Cancer

World J Gastroenterol. Sep 15, 2003; 9(9): 1995-1998
Published online Sep 15, 2003. doi: 10.3748/wjg.v9.i9.1995

Full Size Figure Download Figure

Figure 1 Inhibition of gelatinase activity of LS174T cell by docetaxel. After treated with 0.1, 0.2, 0.5, 1.0 ng/mL concentration of docetaxel, the activity of MMP2 AND 9 was inhibited. Representative results from three independent experiments: Con. docetaxel solvent control group; 1-3: 0.1, 0.5, 1.0 ng/mL concentrations of docetaxel.

Citation: Guo XL, Lin GJ, Zhao H, Gao Y, Qian LP, Xu SR, Fu LN, Xu Q, Wang JJ. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cell. World J Gastroenterol 2003; 9(9): 1995-1998
URL: https://www.wjgnet.com/1007-9327/full/v9/i9/1995.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i9.1995